Patent details

Basic Information

Publication number:

EP2942065

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP151689486

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

HETERODIMERS OF GLUTAMIC ACID

French Title of Invention:

HÉTÉRODIMÈRES D'ACIDE GLUTAMIQUE

German Title of Invention:

HETERODIMERE VON GLUTAMINSÄURE

SPC Number:

Dates

Filing date:

07/11/2007

Grant date:

27/06/2018

EP Publication Date:

11/11/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/06/2018

EP B1 Publication Date:

27/06/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

07/11/2018

Expiration date:

07/11/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/06/2018

 

 

Name:

Molecular Insight Pharmaceuticals, Inc.

Address:

160 Second Street, Cambridge, MA 02142, United States (US)

Inventor

1

Name:

Maresca, Kevin P.

Address:

United States (US)

2

Name:

Babich, John W.

Address:

United States (US)

3

Name:

Zimmerman, Craig N.

Address:

United States (US)

Priority

1

Priority Number:

857490 P

Priority Date:

08/11/2006

Priority Country:

United States (US)

2

Priority Number:

878678 P

Priority Date:

05/01/2007

Priority Country:

United States (US)

Classification

IPC classification:

A61K 51/00; A61P 35/00; C07B 59/00; C07C 275/16; C07C 275/24; C07C 275/30; C07C 311/19; C07D 213/38;

Publication

European Patent Bulletin

Issue number:

201826

Publication date:

27/06/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/03/2019	Outgoing Correspondence	1